[A Case of Histological Complete Remission after Chemotherapy for Paraaortic Lymph Node Recurrence after Colon Cancer Surgery]. 2019

Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
Dept. of General Surgery, Kamitsuga General Hospital.

In September 2013, a 50-year-old woman presented to our hospital with right abdominal pain as the main complaint. Careful examinations led to the diagnosis of ascending colon cancer. In October 2013, resection of the right half colon and removal of the D3 lymph nodes were performed. As postoperative adjunctive chemotherapy, 6 courses of CAPOX therapy were initiated. PET-CT conducted 17 months after the surgery revealed an enlarged right para-aoric lymph nodes and abnormal FDG accumulation. Lymph node recurrence was diagnosed. In April 2015, 10 courses of CAPOX plus BEV therapy, followed by 12courses of capecitabine single agent, were initiated. PET-CT revealed complete remission of the right para-aoric lymph nodes. However, abnormal FDG accumulation was detected in the right ovary and uterine corpus. After careful examinations in March 2017, we performed expanded total hysterectomy, bilateral resection of the appendicular organs, resection of body reticular region, and removal of the lymph nodes and those at the right side of the aorta for the ovarian and uterine cancer. Pathologically, intimal cancer in the right ovary and uterine corpus was diagnosed. Examination of the right para-aoric lymph nodes resected at the same time showed complete remission on images, although histological complete remission was found with scarring. Currently, 63 months after the initial surgery, the patient is alive without recurrence.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072078 Positron Emission Tomography Computed Tomography An imaging technique that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner. This establishes a precise anatomic localization in the same session. CT PET,CT PET Scan,PET CT Scan,PET-CT,PET-CT Scan,Positron Emission Tomography-Computed Tomography,CT PET Scans,CT Scan, PET,CT Scans, PET,PET CT Scans,PET Scan, CT,PET Scans, CT,PET-CT Scans,Scan, CT PET,Scan, PET CT,Scan, PET-CT,Scans, CT PET,Scans, PET CT,Scans, PET-CT
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
November 2016, Gan to kagaku ryoho. Cancer & chemotherapy,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
December 2023, Gan to kagaku ryoho. Cancer & chemotherapy,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
July 2012, The Tokai journal of experimental and clinical medicine,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
November 2010, Gan to kagaku ryoho. Cancer & chemotherapy,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
December 2023, Gan to kagaku ryoho. Cancer & chemotherapy,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
November 2014, Gan to kagaku ryoho. Cancer & chemotherapy,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
September 2003, Gan to kagaku ryoho. Cancer & chemotherapy,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
November 2016, Gan to kagaku ryoho. Cancer & chemotherapy,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
June 2007, Gut and liver,
Itaru Sonoda, and Tsuyoshi Chiku, and Kimio Shinoda, and Takahiro Hashiba, and Wataru Sano, and Yasuhiro Togawa, and Akihiko Toyoda
December 2021, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!